Authors:
Freyer, G
Ligneau, B
Schlumberger, M
Blandy, C
Contedevolx, B
Trillet-Lenoir, V
Lenoir, GM
Chau, N
Dazord, A
Citation: G. Freyer et al., Quality of life in patients at risk of medullary thyroid carcinoma and followed by a comprehensive medical network: Trends for future evaluations, ANN ONCOL, 12(10), 2001, pp. 1461-1465
Authors:
Rohlfs, EM
Puget, N
Graham, ML
Weber, BL
Garber, JE
Skrzynia, C
Halperin, JL
Lenoir, GM
Silverman, LM
Mazoyer, S
Citation: Em. Rohlfs et al., An Alu-mediated 7.1 kb deletion of BRCAI exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10, GENE CHROM, 28(3), 2000, pp. 300-307
Authors:
Magdinier, F
Billard, LM
Wittmann, G
Frappart, L
Benchaib, M
Lenoir, GM
Guerin, JF
Dante, R
Citation: F. Magdinier et al., Regional methylation of the 5 ' end CpG island of BRCA1 is associated withreduced gene expression in human somatic cells, FASEB J, 14(11), 2000, pp. 1585-1594
Authors:
Feldman, GL
Edmonds, MW
Ainsworth, PJ
Schuffenecker, I
Lenoir, GM
Saxe, AW
Talpos, GB
Roberson, J
Petrucelli, N
Jackson, CE
Citation: Gl. Feldman et al., Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG -> ATG) mutation, SURGERY, 128(1), 2000, pp. 93-98
Authors:
Bachelier, R
Dalla Venezia, N
Mazoyer, S
Frappart, L
Lenoir, GM
Vincent, A
Citation: R. Bachelier et al., Differential expression and subcellular localization of murine BRCA1 and BRCA1-Delta 11 isoforms in murine and human cell lines, INT J CANC, 88(4), 2000, pp. 519-524
Authors:
Wautot, V
Khodaei, S
Frappart, L
Buisson, N
Baro, E
Lenoir, GM
Calender, A
Zhang, CX
Weber, G
Citation: V. Wautot et al., Expression analysis of endogenous menin, the product of the multiple endocrine neoplasia type 1 gene, in cell lines and human tissues, INT J CANC, 85(6), 2000, pp. 877-881
Authors:
Unger, MA
Nathanson, KL
Calzone, K
Antin-Ozerkis, D
Shih, HA
Martin, AM
Lenoir, GM
Mazoyer, S
Weber, BL
Citation: Ma. Unger et al., Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing, AM J HU GEN, 67(4), 2000, pp. 841-850
Authors:
Mazoyer, S
Leary, J
Kirk, J
Fleischmann, E
Wagner, T
Claes, K
Messiaen, L
Foulkes, W
Desrochers, M
Simard, J
Phelan, CM
Kwan, E
Narod, SA
Vahteristo, P
Nevanlinna, H
Durando, X
Bignon, YJ
Peyrat, JP
Bonnardel, C
Sinilnikova, OM
Puget, N
Lenoir, GM
Mazoyer, S
Audoynaud, C
Goldgar, D
Maugard, C
Caux, V
Gad, S
Stoppa-Lyonnet, D
Nogues, C
Lidereau, R
Machavoine, C
Bressac-de Paillerets, B
Kuschel, B
Betz, B
Niederacher, D
Beckmann, MW
Hamann, U
Gayther, SA
Ponder, BAP
Robinson, M
Taylor, GR
Bishop, T
Catteau, A
Solomon, E
Cohen, B
Steel, M
Collins, N
Stratton, M
van der Looij, M
Olah, E
Miller, NJ
Barton, DE
Sverdlov, RS
Friedman, E
Radice, P
Montagna, M
Sensi, E
Caligo, M
van Eijk, R
Devilee, P
van der Luijt, R
Heimdal, K
Moller, P
Borg, A
Diez, O
Cortes, J
Domenech, M
Baiget, M
Osorio, A
Benitez, J
Borg, A
Maillet, P
Sappino, AP
Ozdag, H
Ozcelik, T
Ozturk, M
Rohlfs, EM
Boyd, J
McDermott, D
Offit, K
Unger, M
Nathanson, K
Weber, BL
Sellers, TA
Hampton, E
Couch, FJ
Neuhausen, S
Citation: S. Mazoyer et al., The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations, AM J HU GEN, 67(1), 2000, pp. 207-212
Authors:
Takahashi, M
Iwashita, T
Santoro, M
Lyonnet, S
Lenoir, GM
Billaud, M
Citation: M. Takahashi et al., Co-segregation of MEN2 and Hirschsprung's disease: The same mutation of RET with both gain and loss-of-function?, HUM MUTAT, 13(4), 1999, pp. 331-336
Authors:
Geneste, O
Bidaud, C
De Vita, G
Hofstra, RMW
Tartare-Deckert, S
Buys, CHCM
Lenoir, GM
Santoro, M
Billaud, M
Citation: O. Geneste et al., Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signalling effecters to a multifunctional docking site, HUM MOL GEN, 8(11), 1999, pp. 1989-1999
Authors:
Freyer, G
Dazord, A
Schlumberger, M
Conte-Devolx, B
Ligneau, B
Trillet-Lenoir, V
Lenoir, GM
Citation: G. Freyer et al., Psychosocial impact of genetic testing in familial medullary-thyroid carcinoma: A multicentric pilot-evaluation, ANN ONCOL, 10(1), 1999, pp. 87-95
Authors:
Puget, N
Stoppa-Lyonnet, D
Sinilnikova, OM
Pages, S
Lynch, HT
Lenoir, GM
Mazoyer, S
Citation: N. Puget et al., Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions, CANCER RES, 59(2), 1999, pp. 455-461
Authors:
Magdinier, F
Ribieras, S
Lenoir, GM
Frappart, L
Dante, R
Citation: F. Magdinier et al., Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region, ONCOGENE, 17(24), 1998, pp. 3169-3176
Authors:
Chappuis-Flament, S
Pasini, A
De Vita, G
Segouffin-Cariou, C
Fusco, A
Attie, T
Lenoir, GM
Santoro, M
Billaud, M
Citation: S. Chappuis-flament et al., Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteines, ONCOGENE, 17(22), 1998, pp. 2851-2861
Authors:
Pasini, A
Chappuis-Flament, S
Geneste, O
Fournier, L
Schuffenecker, I
Michiels, FM
Feunteun, J
Pelet, A
Lyonnet, S
De Vita, G
Santoro, M
Lenoir, GM
Giraud, S
Billaud, M
Citation: A. Pasini et al., RET, hereditary cancers and congenital malformation: A deregulation model of a tyrosine kinase receptor in human pathology, EUROCANCER 98, 1998, pp. 95-96
Authors:
Serova-Sinilnikova, O
Egan, K
Boutrand, L
Stoppa-Lyonnet, D
Desjardins, L
Levy, C
Bignon, YJ
Lasset, C
Haguenauer, O
Goldgar, D
Lenoir, GM
Citation: O. Serova-sinilnikova et al., Implication of germline BRCA2 gene mutations for the occurrence of ocular melanoma and pancreatic cancer, EUROCANCER 98, 1998, pp. 113-114